| Patient | Geronimo |
|---|---|
| Date of birth | 1949-06-01 |
| Identifiers | MRN HR-NI016-SYN; SSN (made up) 000-16-4729 |
| Document date | 2026-07-22 |
| Author | Roberta Whitehorse-Lindgren, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two-week review of sleep, nightmares and drinking, seen the same day by psychiatry. [S]
Geronimo returns two weeks after intake, with the interpreter, and is seen the same day by Dr. Achebe-Varga, the visiting psychiatrist, who completed the CAPS-5 interview with him this morning. He still sleeps three or four hours a night, with nightmares most nights, and wakes ready to fight. He has cut his drinking from five or six drinks to three or four most evenings, and takes thiamine. His intake tests showed a PEth of 236 ng/mL, AST 58 and GGT 112 U/L with normal kidney function, albumin and bilirubin. A urine test today shows no opioids. He has not fallen again. He would like to try the talking treatment first and is not ready for a medicine for his mood; he will take a medicine for the drinking. [S]
| Element | Detail |
|---|---|
| Sleep | Three or four hours; nightmares most nights |
| Drinking | Three or four drinks most evenings, down from five or six |
| PCL-5 | 54 |
| CAPS-5 | Criteria met in all four symptom clusters; severity 44 |
| Urine drug test | No opioids |
| System | Result | Finding |
|---|---|---|
| Psychiatric | Positive | Nightmares, unwanted memories, startle and poor sleep; no thoughts of suicide |
| Neurological | Negative | No tremor, sweats or confusion when he drinks less |
| Gastrointestinal | Negative | No abdominal pain, jaundice or black stools |
| Musculoskeletal | Negative | Left hip bruise healing; no pain on walking |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Thiamine 100 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-07-08 | active | S |
| Naltrexone 50 mg oral tablet, one tablet daily; carries a wallet card saying that naltrexone blocks opioid pain medicines | One tablet daily | Oral route | 2026-07-22 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-22 | Body height | 173 | cm | S |
| 2026-07-22 | Body weight | 66.2 | kg | S |
| 2026-07-22 | Body mass index (BMI) [Ratio] | 22.1 | kg/m2 | S |
| 2026-07-22 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-07-22 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-07-22 | Heart rate | 78 | /min | S |
| 2026-07-22 | Respiratory rate | 16 | /min | S |
| 2026-07-22 | Body temperature | 36.5 | Cel | S |
| 2026-07-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-22 | PTSD PCL-5 score [PCL-5] | 54 | {score} | S |
Vital signs recorded on 2026-07-22; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 134/78, pulse 78; weight 66.2 kg |
| Mental status | Alert and composed; mood tired; affect restricted; no psychotic symptoms; no thoughts of suicide or of harming anyone |
| Neurological | No tremor; steady gait |
| Abdomen | Liver edge not enlarged; no tenderness |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Poor sleep for many years with nightmares and unwanted memories of past violence, worse over the past year; drinks at night to sleep; cause to be assessed | resolved | confirmed | G47.00 | S — Synthetic presenting problem anchored to the documented killing of his family and his years of war; resolved into the diagnosis of post-traumatic stress disorder at the consultation. Not a claim about his real sleep. |
| Post-traumatic stress disorder, chronic, confirmed with the CAPS-5 interview (PCL-5 56 at intake); prolonged grief disorder considered and criteria not met | active | confirmed | F43.12 | S — Synthetic modern diagnosis made at the consultation by current criteria; not a retrospective diagnosis of the historical person. |
| Alcohol use disorder, moderate (four DSM-5-TR criteria): drinking at night to sleep, more than intended, unable to cut down, and a fall walking home after drinking; AUDIT 19; liver tests show the pattern of heavy drinking | active | confirmed | F10.20 | S — Synthetic modern diagnosis anchored to his own statement that he was twice jailed for drinking whisky as a prisoner of war; not a claim about his real drinking. |
| A fall in the past month while walking home at night after drinking: bruised left hip, no fracture on examination; Timed Up and Go 13 seconds | active | confirmed | Z91.81 | S — Synthetic fall-risk finding; it is not his documented last fall, which is history after the episode. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PTSD symptom severity (PCL-5) | Baseline, then every visit during treatment | Completed today | 54, from 56 at intake |
| Survey | Structured clinician-administered interview (CAPS-5) to confirm the diagnosis | Once at diagnosis; again only if the diagnosis is in doubt | Completed today | Criteria met in all four clusters (intrusion, avoidance, negative mood and thinking, arousal); severity score 44, recorded as narrative |
| Self-management | Trauma-focused psychotherapy (cognitive processing therapy), sessions attended | Weekly for twelve sessions | Ordered | Cognitive processing therapy booked weekly from next week, with the interpreter |
| Survey | Depressive symptoms (PHQ-9) | Baseline, then monthly during active treatment | Up to date | PHQ-9 11 at intake, item 9 scored 0; next at six weeks |
| Survey | Suicide-risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; no firearm; 988 card carried |
| Self-management | Drinking since the last visit, against his own goal | Every visit | Completed today | Three or four drinks most evenings, down from five or six |
| Laboratory | Liver tests (AST, ALT, GGT) on naltrexone | Before starting, at four to six weeks, then every three to six months | Completed today | Before naltrexone: AST 58, ALT 36, GGT 112 U/L at intake; AST under three times the upper limit; creatinine 1.0 mg/dL, eGFR 78 |
| Laboratory | PEth, a blood marker of drinking over the past two to four weeks | At baseline and every one to three months during treatment, with consent | Up to date | 236 ng/mL at intake; next at about eleven weeks |
| Medication safety | Naltrexone safety: opioid use, nausea, wallet card | At the start and every visit | Completed today | Urine test negative for opioids; wallet card given |
| Medication safety | SSRI safety: sodium, bleeding, falls and side effects | Sodium within the first month in older adults; review at each dose change | Not indicated | No SSRI; he chose therapy first |
| Examination | Falls and gait (Timed Up and Go), orthostatic blood pressure | At intake and every visit after a fall | Up to date | Timed Up and Go 13 seconds at intake; no fall since |
| Self-management | Traditional healing alongside clinic care, at his choice | Every visit | Completed today | Offered again; his choice; nothing asked |
| Referral | Psychiatry consultation | At diagnosis | Completed today | Seen by Dr. Achebe-Varga today |
Goal progress:
Guideline basis: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults (2017); The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The Healthcare Professional's Core Resource on Alcohol (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Special General Memorandum 94-08: Statement of Policy for the Traditional Cultural Advocacy Program (1994)
Follow-up: Six-week review with liver tests. Cognitive processing therapy weekly from next week. Call the clinic or 988 at any hour. Next scheduled visit 2026-08-19: six-week review: cognitive processing therapy, naltrexone, sleep, mood and medicine. [S]